Hamilton, NJ (November 16, 2016) – University Urology Associates of New Jersey (UUANJ) now offers another minimally invasive option to the millions of men suffering from the effects of an enlarged prostate. UroLift, the first permanent implant to treat the symptoms caused by an enlarged prostate, is the latest technological advance in UUANJ’s comprehensive collection of treatment options.
The National Institutes of Health reports that over 50% of men in their 60s have symptoms of Benign Prostatic Hyperplasia (BPH) and as many as 500 million men worldwide suffer from BPH-related symptoms. BPH is a common, non-cancerous condition in men where the prostate gland becomes enlarged. Unfortunately, an enlarged prostate can constrict the urethra and cause a wide variety of symptoms including frequent urination or difficulty urinating. BPH symptoms can cause loss of productivity and sleep, depression and decreased quality of life.
“The providers at UUANJ are dedicated to providing the highest level of patient care and a part of that is offering an array of treatment options for urological conditions. The UroLift procedure is a relatively new procedure and a reasonable alternative to drug therapy or more invasive surgery but this procedure is not a one-size-fits-all treatment. Our philosophy is patient-centered care and our goal is to help the patient achieve the best quality of life possible,” said Dr. Mukaram Gazi, a board-certified urologist and president of UUANJ. Dr. Gazi was one of the first urologists in the area to offer the UroLift procedure to patients and is currently one of the top implanters in the region.
Treatment options for BPH range from medications to surgery. The UroLift implants are delivered during a minimally-invasive procedure and act like window curtain tie-backs to hold the lobes of an enlarged prostate open. It is a simple procedure that does not require any cutting, heating or removal of prostate tissue. Patients normally recover from the procedure quickly, and return to their normal routines with minimal downtime.
Data from clinical trials showed that patients receiving UroLift implants reported rapid symptomatic improvement, improved urinary flow rates, and sustained sexual function. Patients also experienced a significant improvement in quality of life. For more information on the UroLift procedure, please visit http://urolift.com/urolift-system/.